Du Wei, Ling Wenwu, Ma Xuelei, Jiang Chong, Wang Jianchao, Zhu Chenjin, Xia Xueming
West China School of Medicine, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Department of Ultrasound, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Oncol Lett. 2017 Oct;14(4):4593-4598. doi: 10.3892/ol.2017.6758. Epub 2017 Aug 16.
Contrast-enhanced computed tomography (CECT) has been extensively used in the restaging and assessment of treatment response for diffuse large B-cell lymphoma (DLBCL). However, CECT does not provide information regarding the specific functionality of lesions. A patient (56 years old, female) was previously admitted to the present institution, with bilateral cervical masses. Following numerous cycles of chemotherapy, a stable disease status was confirmed using CECT. In conjunction with CECT imaging results, contrast-enhanced ultrasound (CEUS) demonstrated important semi-functional information regarding blood perfusion, during the revision of treatment assessment. F-fluoro-2-deoxyglucose (FDG)-positron emission tomography-computed tomography imaging demonstrated no increase in FDG uptake of the same tumor lesion, consistent with the results of CEUS. CEUS exhibited the potential to present complementary results to CECT, in the therapeutic assessment of DLBCL, which, to the best of our knowledge, has not previously been reported.
对比增强计算机断层扫描(CECT)已广泛用于弥漫性大B细胞淋巴瘤(DLBCL)的再分期和治疗反应评估。然而,CECT无法提供有关病变特定功能的信息。一名患者(56岁,女性)此前入住本院,双侧颈部有肿块。经过多个周期的化疗后,CECT确认疾病状态稳定。在治疗评估修订期间,结合CECT成像结果,对比增强超声(CEUS)显示了有关血流灌注的重要半功能信息。F-氟-2-脱氧葡萄糖(FDG)正电子发射断层扫描-计算机断层扫描成像显示同一肿瘤病变的FDG摄取没有增加,与CEUS结果一致。据我们所知,在DLBCL的治疗评估中,CEUS有可能为CECT提供补充结果,这在以前尚未见报道。